title: Modulation of the low-density-lipoprotein-receptor-related protein and its relevance to chylomicron-remnant metabolism.
abstract: Hepatic levels of the low-density-lipoprotein (LDL)-receptor-related protein (LRP) and the LDL receptor were measured in rats subjected to treatments known to affect the expression of the LDL receptor. Propylthiouracil decreased both hepatic LRP and LDL receptor expression by 30-40%. Thyroxine treatment increased LDL receptor levels by 3-fold without altering LRP levels. In contrast, 17 alpha-ethinyloestradiol decreased LRP by 50%, whereas the LDL receptor was increased 5-fold. Plasma chylomicrons and their remnants were decreased to insignificant levels with this treatment. In rats fed with cholesterol there was a significant increase in these particles in plasma (1.21 +/- 0.4 versus 5.71 +/- 0.4 mg/dl), whereas the expression of LRP was unaltered. In Watanabe heritable hyperlipidaemic and cholesterol-fed rabbits, in which the LDL receptor expression is absent or decreased, the expression of LRP was not significantly different from that in normal rabbits. These results suggest that the expression of hepatic LRP can be modulated by changes in the hormonal status of the rat and that this modulation is not tightly co-ordinated with that of the LDL receptor. Moreover, LRP does not appear to have a significant role in chylomicron-remnant clearance, whereas the LDL receptor is actively involved in this process.
authors: Lipid Research Department, University of New South Wales School of Medicine, St. Vincent's Hospital, Sydney, Australia.
authors: A
authors: A
authors: Szanto
authors: S
authors: S
authors: Balasubramaniam
authors: P D
authors: PD
authors: Roach
authors: P J
authors: PJ
authors: Nestel
mesh_terms: D000818:Animals; D002132:Calcium Radioisotopes; D002784:Cholesterol / Q000097:blood / Q000494:pharmacology; D002914:Chylomicrons / Q000097:blood*; D004958:Estradiol / Q000494:pharmacology; D006950:Hyperlipidemia, Familial Combined / Q000097:blood / Q000378:metabolism; D015151:Immunoblotting; D008074:Lipoproteins / Q000032:analysis; D008099:Liver / Q000378:metabolism / Q000502:physiology / Q000648:ultrastructure; D026503:Low Density Lipoprotein Receptor-Related Protein-1; D008297:Male; D008566:Membranes / Q000378:metabolism; D011441:Propylthiouracil / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D017208:Rats, Wistar; D011971:Receptors, Immunologic / Q000378:metabolism / Q000502:physiology*; D011973:Receptors, LDL / Q000378:metabolism / Q000502:physiology*; D013974:Thyroxine / Q000494:pharmacology; D014280:Triglycerides / Q000032:analysis
chemical_list: D002132:Calcium Radioisotopes; D002914:Chylomicrons; D008074:Lipoproteins; D026503:Low Density Lipoprotein Receptor-Related Protein-1; D011971:Receptors, Immunologic; D011973:Receptors, LDL; D014280:Triglycerides; D004958:Estradiol; D011441:Propylthiouracil; D002784:Cholesterol; D013974:Thyroxine